aMoon

aMoon is a global HealthTech and life sciences investment fund headquartered in Israel. The firm partners with exceptional entrepreneurs who harness groundbreaking science and technology to transform healthcare. aMoon operates through multiple funds, including aMoon Velocity, aMoon Growth, and aMoon Edge, investing across the full company lifecycle from early-stage to public equity opportunities.

The firm's investment strategy focuses on sectors such as biotechnology, life sciences, healthcare, digital health, and medtech. aMoon's geographical focus spans Israel, the United States, Europe, and Asia, reflecting its commitment to supporting innovative healthcare solutions worldwide. The firm has a history of investing in companies pursuing disruptive, cutting-edge technologies to address unmet medical needs.

With assets under management estimated at over $1 billion, aMoon has built a strong track record, having made over 70 investments across healthcare and biotech. Notable exits include DayTwo and Omada's IPO. The firm's team comprises over 50 scientists, physicians, entrepreneurs, and investors with global experience, dedicated to accelerating the development of revolutionary ideas in healthcare.